We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$5.53T
AUM Growth
-$210B
Cap. Flow
+$64.1B
Cap. Flow %
1.16%
Top 10 Hldgs %
26.18%
Holding
4,371
New
78
Increased
2,143
Reduced
1,679
Closed
90

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.14B
2
MSFT icon
Microsoft
MSFT
+$2.98B
3
UNH icon
UnitedHealth
UNH
+$2.85B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.59B
5
CRH icon
CRH
CRH
+$2.42B

Sector Composition

Rank Sector Weight
1 Technology 28.01%
2 Financials 14.44%
3 Healthcare 11%
4 Consumer Discretionary 10.05%
5 Industrials 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAL icon
1426
TAL Education Group
TAL
$6.87B
$226M ﹤0.01%
17,139,350
+290,538
+2% +$3.62M
VGK icon
1427
Vanguard FTSE Europe ETF
VGK
$31.4B
$226M ﹤0.01%
3,223,698
+439,565
+16% +$30.3M
TDW icon
1428
Tidewater
TDW
$4.12B
$226M ﹤0.01%
5,345,632
-140,654
-3% -$6.99M
ABR icon
1429
Arbor Realty Trust
ABR
$998M
$225M ﹤0.01%
19,179,358
-341,417
-2% -$4.42M
SMMT icon
1430
Summit Therapeutics
SMMT
$11.1B
$225M ﹤0.01%
11,640,507
-30,069
-0.3% -$603K
SXI icon
1431
Standex International
SXI
$4.12B
$224M ﹤0.01%
1,387,512
-31,191
-2% -$5.72M
VC icon
1432
Visteon
VC
$2.78B
$224M ﹤0.01%
2,882,823
-26,394
-0.9% -$2.22M
CC icon
1433
Chemours
CC
$2.37B
$223M ﹤0.01%
16,487,008
+1,263,047
+8% +$21M
RRR icon
1434
Red Rock Resorts
RRR
$3.62B
$223M ﹤0.01%
5,133,893
-47,253
-0.9% -$2.24M
SEM
1435
DELISTED
Select Medical
SEM
$222M ﹤0.01%
13,316,069
+603,079
+5% +$11.1M
CPRI icon
1436
Capri Holdings
CPRI
$1.74B
$222M ﹤0.01%
11,232,395
-145,235
-1% -$3.22M
DAN icon
1437
Dana Inc
DAN
$3.06B
$222M ﹤0.01%
16,624,715
-261,958
-2% -$3.77M
APLS
1438
DELISTED
Apellis Pharmaceuticals
APLS
$222M ﹤0.01%
10,130,356
+84,331
+0.8% +$2.33M
SHOO icon
1439
Steven Madden
SHOO
$3.55B
$222M ﹤0.01%
8,316,124
+218,785
+3% +$7.7M
WFG icon
1440
West Fraser Timber
WFG
$5.65B
$221M ﹤0.01%
2,876,409
+29,746
+1% +$2.45M
ACLS icon
1441
Axcelis
ACLS
$4.33B
$221M ﹤0.01%
4,439,902
+43,768
+1% +$2.77M
JJSF icon
1442
J&J Snack Foods
JJSF
$1.71B
$220M ﹤0.01%
1,673,976
+20,803
+1% +$2.8M
SNEX icon
1443
StoneX
SNEX
$7.94B
$220M ﹤0.01%
6,482,763
+54,600
+0.8% +$1.83M
LIF
1444
Life360
LIF
$5.12B
$218M ﹤0.01%
5,683,626
+5,540,302
+3,866% +$239M
NU icon
1445
Nu Holdings
NU
$66.9B
$218M ﹤0.01%
21,270,594
+1,660,565
+8% +$19.6M
PII icon
1446
Polaris
PII
$4.07B
$217M ﹤0.01%
5,303,324
-339,139
-6% -$16.1M
VIPS icon
1447
Vipshop
VIPS
$7.53B
$217M ﹤0.01%
13,813,814
-147,588
-1% -$2.23M
LGND icon
1448
Ligand Pharmaceuticals
LGND
$6.36B
$216M ﹤0.01%
2,055,732
-29,895
-1% -$3.38M
ACVA icon
1449
ACV Auctions
ACVA
$1.3B
$216M ﹤0.01%
15,301,225
+1,055,310
+7% +$19.4M
RPD icon
1450
Rapid7
RPD
$773M
$216M ﹤0.01%
8,132,513
-485,967
-6% -$16.5M

Similar funds

Vanguard Group's Q1 2025 Portfolio in Review

As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3.8%. Vanguard Group opened 78 new positions and exited 90, leaving the 4,371-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
  • Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
  • Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
  • Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
  • Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
  • Vanguard Group opened 78 new positions and closed 90 in Q1 2025.
  • Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.

Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.